Midgard Science

Polypeptide

San Diego, CA, United States polypeptide.com

From their website, Nov 2026

Work here? Claim this listing

About

PolyPeptide is a peptide CDMO that develops and manufactures peptide active pharmaceutical ingredients for pharmaceutical and biotech customers worldwide. It supports projects from pre-GMP development and clinical trials through commercial manufacturing, with facilities in Europe, the US, and India.

Services

  • Pre-GMP development

    Develops robust production approaches, analytical characterization, and pilot or pre-GMP toxicology lots before GMP manufacture.

  • GMP peptide manufacturing

    Manufactures GMP-grade peptides from initial gram quantities through commercial multi-kilogram batch requirements.

    CDMO: development & manufacturing

  • Production

    Develops and scales small- to large-scale production processes for proprietary and generic peptides, including complex peptides.

    CDMO: development & manufacturing

  • Quality assurance

    Releases product after batch record review and verifies compliance with cGMP requirements.

  • Quality control

    Performs analytical development and GMP testing procedures to support API release for clinical and commercial material.

  • Regulatory support

    Prepares regulatory documentation and supports interactions with health authorities for IND/IMPD, NDA/MAA, DMFs/ASMFs, and CEPs.

  • Commercial manufacturing

    Manufactures commercial peptide APIs and supports approval and commercialization activities.

    CDMO: development & manufacturing

  • Process development and optimization

    Selects synthesis routes and optimizes manufacturing processes across the product life cycle, including clinical and commercial stages.

  • Capacity and capabilities

    Provides solution-phase, solid-phase, and hybrid peptide manufacturing capabilities across multiple global sites.

  • Custom R&D

    Supports custom research and development projects for peptide-based products.

  • Custom research grade peptides

    Produces research-grade peptides for non-commercial use.

  • Radiolabeled peptide production

    Produces isotopically labeled and radio-labeled peptides at supported sites.

  • Generic peptides

    Manufactures generic peptide products for worldwide supply.

  • Production process development

    Develops small-scale to large-scale production processes for proprietary and generic peptides across development stages.

    CDMO: development & manufacturing

  • GMP compliance and regulatory support

    Supports manufacturing in compliance with ICH Q7 and provides documentation for product approval from IND to NDA.

  • Radiolabeled peptide manufacturing

    Produces radiolabeled peptides.

  • Generic peptide manufacturing

    Provides services for generic peptides.

Lead time
Quick turnaround times
What to send
Clients can request a quote · Manufacturing support for physician sponsored IND, corporate IND, and commercial manufacturing · Lead peptide designated for GMP manufacture · Pilot lots · Pre-GMP animal toxicology lots

Capabilities

As they state on their website or in their listing.

Processes
Small molecule · Peptide · Vaccine · Peptides · Process development · Toxicology
Capacity
From initial gram quantities to multi-kilograms or more per batch · Lot sizes typically up to 1 kg · Up to 6,300L reactor size · Metric tons · 6 sites on 3 continents · Initial gram quantities · Multi-kilograms or more per batch · Mg quantities
Offers
Custom synthesis
Scales
Milligram · Gram · Kilogram

Equipment

  • Solid phase synthesis units
  • Intermediary processing laboratories
  • Purification suites
  • Lyophilizers
  • Reactors up to 200L
  • Reactors up to 650L
  • Reactor size up to 6,300L
  • UHPLC
  • MS/MS

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: quality assurance and quality control

  • ISO 14001Self-reported

    Scope: Malmö site certification

Company

Type
CDMO
Founded
1952
Size
1001-5000 employees
Ownership
Small business, as registered with SAM.gov or stated on their site

Locations

Address
365 Maple Avenue Torrance CA 90503 USA
Sites
Baar, Switzerland · Limhamn, Sweden · Strasbourg, France · Braine-l’Alleud, Belgium · Torrance, USA · San Diego, USA · Ambernath, India · Malmö, Sweden
Serves
North America, Europe, Asia, worldwide, around the globe

Public records

Parent company
PolyPeptide Group AG · CH GLEIF
Biocom California CRO directory
neoantigen, Peptides, small molecule source
FDA drug establishment registration
1000519239 · ANALYSIS; API MANUFACTURE source

Similar labs

Work here? Claim this listing